Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A6

    
• • ·Information for Authors

    Page :A7

    
• • ·Information for Readers

    Page :A9

    

• Editorial

  • ·The pain and the gain of treating patients with acute coronary syndromes—can the two be separated?

    Page :399-401

    Sorin J. Brener, Deepak L. Bhatt

    Plan Plan  

• Review Articles

  • ·Measuring impedance in congestive heart failure: Current options and clinical applications

    Page :402-411

    W.H. Wilson Tang, Wilson Tong

    Résumé Résumé Plan Plan  
  • ·Facts and controversies of aspirin and clopidogrel therapy

    Page :412-422

    David P. Faxon, Jane E. Freedman

    Résumé Résumé Plan Plan  

• Trial Design

  • ·The rationale and design of the FOR?ARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation

    Page :423-427

    Alejandro Macchia, Sergio Varini, Hugo Grancelli, Daniel Nul, Nicolas Laffaye, Daniel Ferrante, Gianni Tognoni, Hernan C. Doval, on behalf of the FORWARD investigators

    Résumé Résumé Plan Plan  
  • ·The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics

    Page :428

    Cheryl Bushnell, Louise Zimmer, Lee Schwamm, Larry B. Goldstein, Nancy Clapp-Channing, Tina Harding, Laura Drew, Xin Zhao, Eric Peterson

    Résumé Résumé Plan Plan  
  • ·Study protocol for a randomized controlled trial: The feasibility and impact of cardiovascular absolute risk assessment in Australian general practice

    Page :436-441

    Qing Wan, Mark F. Harris, Nicholas Zwar, Terry Campbell, Anushka Patel, Sanjyot Vagholkar, Suzanne McKenzie, Christine Walker, Elizabeth Denney-Wilson, on behalf of the ART study group

    Résumé Résumé Plan Plan
  • ·Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study

    Page :442-449

    Julie A. Johnson, Eric Boerwinkle, Issam Zineh, Arlene B. Chapman, Kent Bailey, Rhonda M. Cooper-DeHoff, John Gums, R. Whit Curry, Yan Gong, Amber L. Beitelshees, Gary Schwartz, Stephen T. Turner

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Patient education and provider decision support to control blood pressure in primary care: A cluster randomized trial

    Page :450-456

    Hayden B. Bosworth, Maren K. Olsen, Tara Dudley, Melinda Orr, Mary K. Goldstein, Santanu K. Datta, Felicia McCant, Pam Gentry, David L. Simel, Eugene Z. Oddone

    Résumé Résumé Plan Plan  
  • ·Effects of cardiac resynchronization therapy on long-term quality of life: An analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study

    Page :457-466

    John G.F. Cleland, Melanie J. Calvert, Yves Verboven, Nick Freemantle

    Résumé Résumé Plan Plan  
  • ·National time trends in congenital heart defects, Denmark, 1977-2005

    Page :467

    Nina Øyen, Gry Poulsen, Heather A. Boyd, Jan Wohlfahrt, Peter K.A. Jensen, Mads Melbye

    Résumé Résumé Plan Plan  
  • ·Late cardiac outcomes after pregnancy in women with congenital aortic stenosis

    Page :474-480

    Nikolaos Tzemos, Candice K. Silversides, Jack M. Colman, Judith Therrien, Gary D. Webb, Jennifer Mason, Evelyn Cocoara, Mathew Sermer, Samuel C. Siu

    Résumé Résumé Plan Plan  
  • ·Volumetric evaluation of coronary plaque in patients presenting with acute myocardial infarction or stable angina pectoris—a multislice computerized tomography study

    Page :481-487

    Sophia Hammer-Hansen, Klaus Fuglsang Kofoed, Henning Kelbæk, Thomas Kristensen, Jørgen Tobias Kühl, Jens Jakob Thune, Lars Køber

    Résumé Résumé Plan Plan  
  • ·Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial: Rationale and design

    Page :488

    Paul S. Myles, Kate Leslie, Philip Peyton, Michael Paech, Andrew Forbes, Matthew T.V. Chan, Daniel Sessler, Philip J. Devereaux, Brendan S. Silbert, Konrad Jamrozik, Scott Beattie, Neal Badner, James Tomlinson, Sophia Wallace, the ANZCA Trials Group

    Résumé Résumé Plan Plan
  • ·Coffee consumption and mortality after acute myocardial infarction: The Stockholm Heart Epidemiology Program

    Page :495-501

    Kenneth J. Mukamal, Johan Hallqvist, Niklas Hammar, Rickard Ljung, Katalin Gémes, Anders Ahlbom, Staffan Ahnve, Imre Janszky

    Résumé Résumé Plan Plan
  • ·Correction

    Page :501

    
  • ·Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk

    Page :502-508

    Campbell D. Joyner, Ron J.G. Peters, Rizwan Afzal, Susan Chrolavicius, Shamir R. Mehta, Keith A.A. Fox, Christopher B. Granger, Maria Grazia Franzosi, Marcus Flather, Andrzej Budaj, Jean-Pierre Bassand, Salim Yusuf

    Résumé Résumé Plan Plan  
  • ·Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study

    Page :509

    Yufang Bi, Runlin Gao, Anushka Patel, Steve Su, Wei Gao, Dayi Hu, Dejia Huang, Lingzhi Kong, Wenhang Qi, Yangfeng Wu, Yuejin Yang, Fiona Turnbull, on behalf of the CPACS Investigators

    Résumé Résumé Plan Plan  
  • ·Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction

    Page :517-524

    Roberto R. Giraldez, Marc S. Sabatine, David A. Morrow, Satishkumar Mohanavelu, Carolyn H. McCabe, Elliott M. Antman, Eugene Braunwald

    Résumé Résumé Plan Plan  
  • ·Blood pressure paradox in patients with non–ST-segment elevation acute coronary syndromes : Results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) quality improvement initiative

    Page :525-531

    Sripal Bangalore, Franz H. Messerli, Fang-Shu Ou, Jacqueline Tamis-Holland, Angela Palazzo, Matthew T. Roe, Mun K. Hong, Eric D. Peterson, for the CRUSADE Investigators

    Résumé Résumé Plan Plan  
  • ·Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: From early reduction in reocclusion to improved long-term clinical outcome

    Page :532-540

    Paul J.P.C. van den Bergh, Peter C. Kievit, Marc A. Brouwer, Wim R.M. Aengevaeren, Gerrit Veen, Freek W.A. Verheugt

    Résumé Résumé Plan Plan  
  • ·Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: Results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac Magnetic Resonance Imaging substudy

    Page :541-547

    Thorsten Dill, Volker Schächinger, Andreas Rolf, Susanne Möllmann, Holger Thiele, Harald Tillmanns, Birgit Assmus, Stefanie Dimmeler, Andreas M. Zeiher, Christian Hamm

    Résumé Résumé Plan Plan  
  • ·The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia : A Report From the Women's Ischemia Syndrome Evaluation (WISE)

    Page :548-555

    Vera Bittner, B. Delia Johnson, Issam Zineh, William J. Rogers, Diane Vido, Oscar C. Marroquin, C. Noel Bairey-Merz, George Sopko

    Résumé Résumé Plan Plan  
  • ·Risk factor management after myocardial infarction: Reported adherence and outcomes

    Page :556-562

    Carole Decker, Homaa Ahmad, Kate Louise Moreng, Thomas M. Maddox, Kimberly J. Reid, Philip G. Jones, John A. Spertus

    Résumé Résumé Plan Plan  
  • ·Assessment of P2Y₁₂ inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

    Page :562.e1

    Christoph Varenhorst, Stefan James, David Erlinge, Oscar Ö. Braun, John T. Brandt, Kenneth J. Winters, Joseph A. Jakubowski, Sylvia Olofsson, Lars Wallentin, Agneta Siegbahn

    Résumé Résumé Plan Plan  
  • ·Adverse association between diabetic retinopathy and cardiac structure and function

    Page :563-568

    David Aguilar, D. Michael Hallman, Linda B. Piller, Barbara E.K. Klein, Ronald Klein, Richard B. Devereux, Donna K. Arnett, Victor H. Gonzalez, Craig L. Hanis

    Résumé Résumé Plan Plan
  • ·Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: Early and medium-term outcome

    Page :569

    Corrado Lettieri, Stefano Savonitto, Stefano De Servi, Giulio Guagliumi, Guido Belli, Alessandra Repetto, Emanuela Piccaluga, Alessandro Politi, Federica Ettori, Battistina Castiglioni, Franco Fabbiocchi, Nicoletta De Cesare, Giuseppe Sangiorgi, Giuseppe Musumeci, Marco Onofri, Maurizio D'Urbano, Salvatore Pirelli, Roberto Zanini, Silvio Klugmann, on behalf of the LombardIMA Study Group r

    Résumé Résumé Plan Plan  
  • ·N-acetylcysteine versus AScorbic acid for Preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography : NASPI study—a prospective randomized controlled trial

    Page :576-583

    Sang-Ho Jo, Bon-Kwon Koo, Jin-Shik Park, Hyun-Jae Kang, Yong-Jin Kim, Hack-Lyoung Kim, In-Ho Chae, Dong-Ju Choi, Dae-Won Sohn, Byung-Hee Oh, Young-Bae Park, Yun-Shik Choi, Hyo-Soo Kim

    Résumé Résumé Plan Plan  
  • ·Effect of thrombus aspiration on infarct size and left ventricular function in high-risk patients with acute myocardial infarction treated by percutaneous coronary intervention. Results of a prospective controlled pilot study

    Page :583.e1

    Janusz Lipiecki, Séverine Monzy, Nicolas Durel, Florent Cachin, Pascal Chabrot, Aurelien Muliez, Dominique Morand, Jean Maublant, Jean Ponsonnaille

    Résumé Résumé Plan Plan
  • ·Coronary artery fistula associated with Kawasaki disease

    Page :584-588

    Chi-Di Liang, Ho-Chang Kuo, Kuender D. Yang, Chih-Lu Wang, Sheung-Fat Ko

    Résumé Résumé Plan Plan  
  • ·Heparin/PF4 antibodies formation after heparin treatment: Temporal aspects and long-term follow-up

    Page :589-595

    Anna Vittoria Mattioli, Lorenzo Bonetti, Mauro Zennaro, Giuseppe Ambrosio, Giorgio Mattioli

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Role of aldosterone receptor antagonist eplerenone in aortic stenosis

    Page :e13

    Radhakrishnan Ramaraj

    
  • ·Letter to the Editor

    Page :e15

    Thomas A. Marciniak

     
  • ·Reply to: Role of aldosterone receptor antagonist eplerenone in aortic steroids

    Page :e17

    Ralph A.H. Stewart, Harvey D. White, for the New Zealand Eplerenone Aortic Stenosis Study Investigators